The eye-opening findings were presented during the Great Wall International Congress of Cardiology 2020 virtual meeting.
Irreversible electroporation, the authors noted, could help clinicians avoid the drawbacks of thermal ablation
Chloroquine, however, was not found to have such an effect.
Catheter ablation was consistently linked to more substantial LVEF improvements than pharmacological therapy.
“These observations might have direct treatment implications," researchers wrote.
Five companies received warnings from the FDA for illegally selling supplements containing cesium chloride.
The authors did emphasize that they were not ruling on the overall “clinical efficacy” of hydroxychloroquine with this research.
Researchers explored data from more than 1,300 COVID-19 patients, sharing their findings in JAMA Internal Medicine.
Innovate Healthcare thanks our partners for supporting our newsletters.Sponsorship has no influence on editorial content.Interested in reaching our audiences, contact our team*|LIST:ADDRESSLINE|*You received this email because you signed up for newsletters from Innovate Healthcare.Change your preferences or unsubscribe hereContact Us | Unsubscribe from all | Privacy Policy© Innovate Healthcare, a TriMed Media brand